Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman Relkin

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Clinical Immunology|April 25, 2014
Clinical trials of intravenous immunoglobulin for Alzheimer's diseaseNorman Relkin
Alzheimer Disease and Associated Disorders|June 15, 2006
Are cholinesterase inhibitors more than symptomatic treatments for Alzheimer disease?Norman Relkin
Seminars in Neurology|January 18, 2007
Normal pressure hydrocephalusDiamanto Tsakanikas, Norman Relkin
Current Alzheimer Research|August 14, 2014
Intravenous immunoglobulins for Alzheimer's diseaseLakshman Puli, Heikki Tanila, Norman Relkin
Handbook of Clinical Neurology|July 18, 2008
Cholinergic components of frontal lobe function and dysfunctionLaura A Rabin, Patima Tanapat, Norman Relkin
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2008
Disease-modifying approaches to Alzheimer's disease: challenges and opportunities-Lessons from donepezil therapyMarwan N Sabbagh, Sharon Richardson, Norman Relkin
Autoimmunity Reviews|June 19, 2008
Natural human antibodies to amyloid beta peptidePaul Szabo, Norman Relkin, Marc E Weksler
Brain Connectivity|July 17, 2013
The Network Modification (NeMo) Tool: elucidating the effect of white matter integrity changes on cortical and subcortical structural connectivityAmy Kuceyeski, Jun Maruta, Norman Relkin, et al.
Journal of the American Geriatrics Society|September 3, 2004
Pesticide exposure and dementiaGazala Darvesh, Gisele Wolf-Klein, Norman Relkin, et al.
Clinical Chemistry|August 5, 2006
Proteomic analysis of cerebrospinal fluid changes related to postmortem intervalErin J Finehout, Zsofia Franck, Norman Relkin, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Immunology|April 25, 2014
Clinical trials of intravenous immunoglobulin for Alzheimer's diseaseNorman Relkin
Alzheimer Disease and Associated Disorders|June 15, 2006
Are cholinesterase inhibitors more than symptomatic treatments for Alzheimer disease?Norman Relkin
Seminars in Neurology|January 18, 2007
Normal pressure hydrocephalusDiamanto Tsakanikas, Norman Relkin
Current Alzheimer Research|August 14, 2014
Intravenous immunoglobulins for Alzheimer's diseaseLakshman Puli, Heikki Tanila, Norman Relkin
Handbook of Clinical Neurology|July 18, 2008
Cholinergic components of frontal lobe function and dysfunctionLaura A Rabin, Patima Tanapat, Norman Relkin
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2008
Disease-modifying approaches to Alzheimer's disease: challenges and opportunities-Lessons from donepezil therapyMarwan N Sabbagh, Sharon Richardson, Norman Relkin
Autoimmunity Reviews|June 19, 2008
Natural human antibodies to amyloid beta peptidePaul Szabo, Norman Relkin, Marc E Weksler
Brain Connectivity|July 17, 2013
The Network Modification (NeMo) Tool: elucidating the effect of white matter integrity changes on cortical and subcortical structural connectivityAmy Kuceyeski, Jun Maruta, Norman Relkin, et al.
Journal of the American Geriatrics Society|September 3, 2004
Pesticide exposure and dementiaGazala Darvesh, Gisele Wolf-Klein, Norman Relkin, et al.
Clinical Chemistry|August 5, 2006
Proteomic analysis of cerebrospinal fluid changes related to postmortem intervalErin J Finehout, Zsofia Franck, Norman Relkin, et al.
Pageof 4